ACP3 and cancer: Sipuleucel-T (known as Provenge® or APC8015) represents an innovative cancer vaccine derived from autologous dendritic cells (DC) that are infused with a specially engineered fusion protein consisting of prostatic acid phosphatase (PAP) and granulocyte-macrophage colony-stimulating factor (GM-CSF).